Home › NDC Lookup › RxCUI directory › RxCUI 2472161

Ansuvimab-zykl 400 MG Injection [Ebanga] — RxCUI 2472161

RxNorm drug concept · Semantic branded drug
RxCUI 2472161 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2472161
Official nameAnsuvimab-zykl 400 MG Injection [Ebanga]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asEbanga 400 MG Injection
FDA products mapped2
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ansuvimab: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ebanga is the brand name for ansuvimab — a lab-made antibody designed specifically to fight Ebola virus disease caused by the Zaire strain of Ebola. It's approved for adults, child...
  • What exactly is Ebanga and what is it used for?
  • Neither — it's given as an IV infusion directly into a vein, over about 60 minutes, once. You won't be preparing or taking anything at home. A healthcare team handles everything: d...
  • How is Ebanga given — do I take a pill or get a shot?
📖 Read our full Ansuvimab guide →

🕸️ Concept Web — How Ansuvimab-zykl 400 MG Injection [Ebanga] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ansuvimab-zykl 400 MG Injection [Ebanga] RxCUI 2472161

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ansuvimab 2472152
    • Ansuvimab-zykl 2472151
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ebanga 2472157
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ansuvimab Injection 2472155
    • Ansuvimab-zykl Injection 2648493
    • Ansuvimab Injectable Product 2472154
    • Ansuvimab-zykl Injectable Product 2659538
    • Ansuvimab Injection [Ebanga] 2472159
    • Ansuvimab-zykl Injection [Ebanga] 2657078
    • Ebanga Injectable Product 2472160
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ansuvimab-zykl 400 MG Injection SCD · 2472156
  • Ansuvimab-zykl 400 MG SCDC · 2472153
  • Ansuvimab Injection SCDF · 2472155
  • Ansuvimab-zykl Injection SCDFP · 2648493
  • Ansuvimab Injectable Product SCDG · 2472154
  • Ansuvimab-zykl Injectable Product SCDGP · 2659538

Brand-Name Concepts

  • Ansuvimab-zykl 400 MG [Ebanga] SBDC · 2472158
  • Ansuvimab Injection [Ebanga] SBDF · 2472159
  • Ansuvimab-zykl Injection [Ebanga] SBDFP · 2657078
  • Ebanga Injectable Product SBDG · 2472160
  • Ebanga BN · 2472157

📦 FDA Products & Package NDCs

2 products · 6 package NDCs
6 package NDCs map to RxCUI 2472161 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71655-0578-03 1 CARTON in 1 BOX (71655-578-03) / 36 VIAL, GLASS in 1 CART... Ebanga Emergent Manufacturing Operations Baltimore, LLC 2020-12-21
71655-0578-04 4 CARTON in 1 BOX (71655-578-04) / 36 VIAL, GLASS in 1 CART... Ebanga Emergent Manufacturing Operations Baltimore, LLC 2020-12-21
71655-0578-08 8 CARTON in 1 BOX (71655-578-08) / 36 VIAL, GLASS in 1 CART... Ebanga Emergent Manufacturing Operations Baltimore, LLC 2020-12-21
80673-0777-01 1 CARTON in 1 BOX (80673-777-01) / 1 KIT in 1 CARTON * 36... EBANGA Ridgeback Biotherapeutics, LP 2020-12-21
80673-0777-04 4 CARTON in 1 BOX (80673-777-04) / 1 KIT in 1 CARTON * 36... EBANGA Ridgeback Biotherapeutics, LP 2020-12-21
80673-0777-08 8 CARTON in 1 BOX (80673-777-08) / 1 KIT in 1 CARTON * 36... EBANGA Ridgeback Biotherapeutics, LP 2020-12-21
Observed labelers: Emergent Manufacturing Operations Baltimore, LLC (3) · Ridgeback Biotherapeutics, LP (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.